Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...
ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight
DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...
Circle set to roll out USDC in Japan after securing FSA approval
The rollout of USDC follows Circle and SBI Holdings securing regulatory approval from the Japan Financial Services Agency ...
Skincare Supplement Market to Reach USD 5,857.59 million by 2032, growing at a 8.50% CAGR - Credence Research
The global Skincare Supplement Market is experiencing significant expansion, driven by increasing consumer awareness ...
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan
Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional ...
San Diego Union-Tribune22h
San Diego Union-Tribune
🛥️ Things to do this week 📚 New bookstore opens in downtown S.D. 🏢 DOGE targets S.D. offices 👟 Hike of the week: Gonzales Canyon 🚗 Tesla sales fall in S.D.